- Home
- CLDX vs FBP Comparison
CLDX vs FBP Comparison
Compare CLDX & FBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDX
- FBP
- Stock Information
- Founded
- CLDX N/A
- FBP 1948
- Country
- CLDX United States
- FBP United States
- Employees
- CLDX N/A
- FBP N/A
- Industry
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- FBP Major Banks
- Sector
- CLDX Health Care
- FBP Finance
- Exchange
- CLDX Nasdaq
- FBP Nasdaq
- Market Cap
- CLDX 1.9B
- FBP 3.4B
- IPO Year
- CLDX 2008
- FBP N/A
- Fundamental
- Price
- CLDX $26.70
- FBP $20.38
- Analyst Decision
- CLDX Buy
- FBP Buy
- Analyst Count
- CLDX 10
- FBP 4
- Target Price
- CLDX $44.20
- FBP $24.25
- AVG Volume (30 Days)
- CLDX 863.9K
- FBP 1.1M
- Earning Date
- CLDX 11-03-2025
- FBP 10-23-2025
- Dividend Yield
- CLDX N/A
- FBP 3.53%
- EPS Growth
- CLDX N/A
- FBP 13.12
- EPS
- CLDX N/A
- FBP 2.05
- Revenue
- CLDX $5,790,000.00
- FBP $902,789,000.00
- Revenue This Year
- CLDX N/A
- FBP $13.19
- Revenue Next Year
- CLDX N/A
- FBP $5.73
- P/E Ratio
- CLDX N/A
- FBP $9.94
- Revenue Growth
- CLDX N/A
- FBP 3.91
- 52 Week Low
- CLDX $14.40
- FBP $16.40
- 52 Week High
- CLDX $29.38
- FBP $22.61
- Technical
- Relative Strength Index (RSI)
- CLDX 52.91
- FBP 40.91
- Support Level
- CLDX $25.97
- FBP $19.74
- Resistance Level
- CLDX $28.59
- FBP $21.25
- Average True Range (ATR)
- CLDX 1.26
- FBP 0.70
- MACD
- CLDX -0.18
- FBP -0.14
- Stochastic Oscillator
- CLDX 44.41
- FBP 26.65
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.
About FBP First BanCorp. New
First BanCorp is a financial holding company. The company's operating segment includes Commercial and Corporate Banking; Mortgage Banking; Consumer (Retail) Banking; Treasury and Investments; United States Operations; and Virgin Islands Operations. It generates maximum revenue from the Consumer (Retail) Banking segment. The Consumer (Retail) Banking segment generates majority revenue, which consists of the Corporation's consumer lending and deposit-taking activities conducted mainly through its branch network and loan centres. Geographically, it derives a majority of revenue from Puerto Rico.